The clinical challenges of akathisia

@article{Lohr2015TheCC,
  title={The clinical challenges of akathisia},
  author={James B. Lohr and Carolyn A. Eidt and Areej Abdulrazzaq Alfaraj and Mounir A. Soliman},
  journal={CNS Spectrums},
  year={2015},
  volume={20},
  pages={1 - 16}
}
Akathisia is one of the most vexing problems in neuropsychiatry. Although it is one of the most common side effects of antipsychotic medications, it is often difficult to describe by patients, and is difficult to diagnose and treat by practitioners. Akathisia is usually grouped with extrapyramidal movement disorders (ie, movement disorders that originate outside the pyramidal or corticospinal tracts and generally involve the basal ganglia). Yet, it can present as a purely subjective clinical… Expand
The psychopharmacology of catatonia, neuroleptic malignant syndrome, akathisia, tardive dyskinesia, and dystonia.
TLDR
Although highly prevalent, motor syndromes in psychiatry and motor side effects of psychopharmacologic agents remain understudied and a balanced and well-advised prescription of antipsychotics is of utmost importance. Expand
Cariprazine and akathisia, restlessness, and extrapyramidal symptoms in patients with bipolar depression.
TLDR
In patients with bipolar depression, the incidence of cariprazine-related akathisia was higher than acute EPS or restlessness, with lower caripazine doses associated with lower incidences of events. Expand
Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis
TLDR
A systematic review and meta-analysis of akathisia incidence rates of the NAPs, as monotherapy or adjunctive treatment, in adult patients with a severe mental illness, using data from published and unpublished randomized controlled trials to assess the role of study characteristics. Expand
Revisiting Antipsychotic-induced Akathisia: Current Issues and Prospective Challenges
TLDR
Despite the initial promise that second generation antipsychotics would be devoid of akathisia effects, this has not been confirmed and the evidence supporting the most widely used treatments (beta blockers, anticholinergic drugs) is still absent or inconsistent. Expand
Risperidone-Induced Tardive Akathisia: A Rare Antipsychotic Side Effect with Management Issues
TLDR
A case of akathisia is reported that occurred after 10 months of starting atypical antipsychotic, risperidone, and challenges faced in management. Expand
Escitalopram-induced severe akathisia leading to suicide attempt
TLDR
A case of severe akathisia leading to a suicide attempt in a 25-year-old male induced by 5 mg of escitalopram, that remitted completely after discontinuation of escITALopram and did not reappear later. Expand
Trichotillomania and Trichophagia: Modern Diagnostic and Therapeutic Methods
TLDR
The aim of this study is to critically review current literature regarding diagnostic procedures and treatment of trichotillomania, including psychotherapy, N-acetylcysteine, naltrexone, topiramate, atypical neuroleptics, and selective serotonin-reuptake inhibitors, and determine the effectiveness of different treatment methods. Expand
Review of cariprazine in management of psychiatric illness.
TLDR
The objective of this article is to review the literature regarding efficacy and tolerability of cariprazine in the management of psychiatric disorders to determine its current place in therapy. Expand
Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT2a Receptor Antagonists
TLDR
Accumulating evidence during the last two decades indicates that agents with marked postsynaptic serotonin 5-HT2a receptor antagonism may represent a new class of potential anti-akathisia remedies and low-dose mirtazapine has demonstrated the most compelling evidence for therapeutic efficacy. Expand
Clinical management of restless legs syndrome in end-stage renal disease patients
TLDR
Limited information is available on the effects of dopamine agonists, levodopa, gabapentin, benzodiazepines, and opioids on end-stage renal disease patients, and further clinical studies are still needed to better assess the efficacy, safety, and tolerability of these medications in patients with ESRD. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 123 REFERENCES
Akathisia: a comprehensive review and treatment summary.
TLDR
There are now valid and reliable methods to assess akathisia using standardized scales; doing so helps track the progress of treatment interventions and an overall treatment algorithm incorporating knowledge to date is presented. Expand
Akathisia, pseudoakathisia and tardive dyskinesia: clinical examples.
TLDR
A review of the literature on akathisia and tardive dyskinesia suggests several possible important relationships between these disorders. Expand
Symptoms of agitated depression and/or akathisia.
TLDR
It is necessary to have akathisia in mind when using certain medicaments, especially when combining several that use the same enzymatic system and consequently raise levels of at least one of them. Expand
The causes of underdiagnosing akathisia.
  • S. Hirose
  • Medicine, Psychology
  • Schizophrenia bulletin
  • 2003
TLDR
What causes clinicians to overlook or underdiagnose akathisia is reviewed to be related to both the patient's symptoms and the clinician's attitude toward akath isia. Expand
Akathisia and second-generation antipsychotic drugs
TLDR
Even though akathisia is less prevalent with SGAs than with the first-generation drugs, it remains clinically important and all clinicians should be conversant with its recognition and management. Expand
Neuroleptics. Violence as a manifestation of akathisia.
TLDR
To my knowledge, however, the literature does not contain reports that the development of akathisia can precipitate violence, resulting in the behavior the drug was meant to alleviate. Expand
The Mechanism of Drug-induced Akathisia
TLDR
A possible mechanism for drug-induced akathisia based on the differential functions of the core and shell portions of the nucleus accumbens is described based on contemporary concepts regarding the mechanisms of compulsion, impulsivity, and depression. Expand
Akathisia following traumatic brain injury: treatment with bromocriptine.
  • J. Stewart
  • Medicine
  • Journal of neurology, neurosurgery, and psychiatry
  • 1989
TLDR
There is strong animal evidence that akathisia may be related to blockade of dopamine in the prefrontal cortex rather than the striatum, and a patient who developed severe motor restlessness following bilateral prefrontal brain injury responded dramatically to bromocriptine, lending further support to this hypothesis. Expand
Akathisia and tardive dyskinesia. Changing concepts.
  • S. Stahl
  • Psychology, Medicine
  • Archives of general psychiatry
  • 1985
TLDR
The article by Barnes and Braude 4 in this issue of theArchives deals with one of the relatively neglected side effects of the first-generation neuroleptics, namely akathisia. Expand
The epidemiology of drug-induced akathisia: Part II. Chronic, tardive, and withdrawal akathisias.
  • P. Sachdev
  • Psychology, Medicine
  • Schizophrenia bulletin
  • 1995
TLDR
The studies suggest that a significant proportion of patients chronically treated with neuroleptics suffer from akathisia, and the prevalence may be as high as 40 percent, although a conservative estimate would be closer to 30 percent. Expand
...
1
2
3
4
5
...